• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ellipsys血管通路系统用于青少年经皮动静脉内瘘创建的初步经验:一例报告。

Initial experience with the Ellipsys Vascular Access System for percutaneous arteriovenous fistula creation in adolescents: A case report.

作者信息

Koo Kevin S H, Monroe Eric J, Reis Joseph, Shivaram Giridhar M, Munshi Raj

机构信息

Department of Radiology, Section of Interventional Radiology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.

Division of Pediatric Nephrology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.

出版信息

Radiol Case Rep. 2020 Dec 17;16(3):441-447. doi: 10.1016/j.radcr.2020.12.026. eCollection 2021 Mar.

DOI:10.1016/j.radcr.2020.12.026
PMID:33363679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7753092/
Abstract

This retrospective, single center, case report describes the first use of the Ellipsys Vascular Access System for percutaneous arteriovenous fistula (pAVF) creation in children. Two adolescent (<20 year of age) patients (18 and 19-year-old females), one of whom was developmentally delayed, were not considered candidates for traditional surgical arteriovenous fistula creation. pAVF creation was successful in both patients using the Ellipsys device and physiologic maturation of the fistula was achieved within 8 weeks of creation with subsequent 2 needle cannulation. No complications or adverse events were encountered. pAVF creation with the Ellipsys device can be safely performed in adolescents. Further studies will be needed to validate the expanded use of these devices in children.

摘要

本回顾性单中心病例报告描述了首次使用Ellipsys血管通路系统为儿童创建经皮动静脉内瘘(pAVF)的情况。两名青少年(年龄<20岁)患者(18岁和19岁女性),其中一名发育迟缓,被认为不适合进行传统的外科动静脉内瘘创建手术。使用Ellipsys装置在两名患者中成功创建了pAVF,并且在创建后的8周内实现了内瘘的生理性成熟,随后进行了双针穿刺。未遇到并发症或不良事件。使用Ellipsys装置为青少年安全地创建pAVF是可行的。需要进一步的研究来验证这些装置在儿童中的广泛应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a598/7753092/3d9bd5d20194/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a598/7753092/1853e6af6be6/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a598/7753092/1f1ab901eb2c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a598/7753092/3d9bd5d20194/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a598/7753092/1853e6af6be6/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a598/7753092/1f1ab901eb2c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a598/7753092/3d9bd5d20194/gr3.jpg

相似文献

1
Initial experience with the Ellipsys Vascular Access System for percutaneous arteriovenous fistula creation in adolescents: A case report.Ellipsys血管通路系统用于青少年经皮动静脉内瘘创建的初步经验:一例报告。
Radiol Case Rep. 2020 Dec 17;16(3):441-447. doi: 10.1016/j.radcr.2020.12.026. eCollection 2021 Mar.
2
Midterm results of percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System, technical recommendations, and an algorithm for maintenance.经 Ellipsys 血管通路系统行经皮动静脉瘘创建的中期结果、技术建议和维护算法。
J Vasc Surg. 2020 Dec;72(6):2097-2106. doi: 10.1016/j.jvs.2020.02.048. Epub 2020 Apr 8.
3
Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys® vascular access system.使用Ellipsys®血管通路系统建立经皮动静脉内瘘的临床血液透析经验。
Hemodial Int. 2019 Apr;23(2):167-172. doi: 10.1111/hdi.12738. Epub 2019 Mar 1.
4
Anatomic suitability for commercially available percutaneous arteriovenous fistula creation systems.商业可用的经皮动静脉瘘创建系统的解剖适用性。
J Vasc Surg. 2021 Mar;73(3):999-1004. doi: 10.1016/j.jvs.2020.09.021. Epub 2020 Oct 15.
5
Early results of percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System.Ellipsys 血管通路系统经皮动静脉瘘创建的早期结果。
J Vasc Surg. 2018 Oct;68(4):1150-1156. doi: 10.1016/j.jvs.2018.01.036. Epub 2018 Apr 19.
6
The past and the future of vascular access surgery: Creation of percutaneous arteriovenous fistula using Ellipsys vascular access system in a patient with previous ipsilateral Scribner-shunt.血管通路手术的过去与未来:在一名既往有同侧Scribner分流的患者中使用Ellipsys血管通路系统创建经皮动静脉内瘘
J Vasc Access. 2021 Nov;22(6):1032-1035. doi: 10.1177/1129729820969323. Epub 2020 Nov 23.
7
Comparison of Outcomes of Percutaneous Arteriovenous Fistulae Creation by Ellipsys and WavelinQ Devices.Ellipsys和WavelinQ设备创建经皮动静脉内瘘的结果比较。
J Vasc Interv Radiol. 2020 Sep;31(9):1365-1372. doi: 10.1016/j.jvir.2020.06.008. Epub 2020 Aug 11.
8
Technical aspects of percutaneous endovascular arteriovenous fistula creation with the Ellipsys® Vascular Access System. Preliminary results after 16 patients.经皮腔内血管动静脉瘘创建的技术方面,采用 Ellipsys®血管通路系统。16 例患者的初步结果。
Langenbecks Arch Surg. 2023 Feb 15;408(1):91. doi: 10.1007/s00423-023-02812-9.
9
Percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System-the state of the art.使用Ellipsys血管通路系统进行经皮动静脉内瘘创建——最新技术水平
J Vasc Surg Cases Innov Tech. 2020 Dec 29;7(3):506-507. doi: 10.1016/j.jvscit.2020.12.009. eCollection 2021 Sep.
10
A systematic review aggregated data and individual participant data meta-analysis of percutaneous endovascular arteriovenous fistula.经皮腔内血管动静脉瘘的系统评价汇总数据和个体参与者数据荟萃分析。
J Vasc Surg. 2023 Apr;77(4):1252-1261.e3. doi: 10.1016/j.jvs.2022.10.039. Epub 2022 Oct 31.

本文引用的文献

1
Maturation for Hemodialysis in the Ellipsys Post-Market Registry.Ellipsys上市后注册研究中血液透析的成熟情况。
J Vasc Interv Radiol. 2020 Sep;31(9):1373-1381. doi: 10.1016/j.jvir.2020.03.001. Epub 2020 Aug 14.
2
Comparison of Outcomes of Percutaneous Arteriovenous Fistulae Creation by Ellipsys and WavelinQ Devices.Ellipsys和WavelinQ设备创建经皮动静脉内瘘的结果比较。
J Vasc Interv Radiol. 2020 Sep;31(9):1365-1372. doi: 10.1016/j.jvir.2020.06.008. Epub 2020 Aug 11.
3
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update.
KDIGO 临床实践指南:血管通路 2019 更新版。
Am J Kidney Dis. 2020 Apr;75(4 Suppl 2):S1-S164. doi: 10.1053/j.ajkd.2019.12.001. Epub 2020 Mar 12.
4
Midterm results of percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System, technical recommendations, and an algorithm for maintenance.经 Ellipsys 血管通路系统行经皮动静脉瘘创建的中期结果、技术建议和维护算法。
J Vasc Surg. 2020 Dec;72(6):2097-2106. doi: 10.1016/j.jvs.2020.02.048. Epub 2020 Apr 8.
5
Two-year cumulative patency of endovascular arteriovenous fistula.血管内动静脉瘘的两年累积通畅率
J Vasc Access. 2020 May;21(3):350-356. doi: 10.1177/1129729819877780. Epub 2019 Sep 28.
6
A national study of autogenous arteriovenous access use and patency in a contemporary hemodialysis population.一项针对当代血液透析人群自体动静脉内瘘使用和通畅情况的全国性研究。
J Vasc Surg. 2019 Jun;69(6):1889-1898. doi: 10.1016/j.jvs.2018.10.063. Epub 2018 Dec 21.
7
Comparison between Surgical and Endovascular Hemodialysis Arteriovenous Fistula Interventions and Associated Costs.手术与血管内血液透析动静脉内瘘干预及相关成本的比较。
J Vasc Interv Radiol. 2018 Nov;29(11):1558-1566.e2. doi: 10.1016/j.jvir.2018.05.014. Epub 2018 Oct 5.
8
A Review of the Current Status of Percutaneous Endovascular Arteriovenous Fistula Creation for Haemodialysis Access.血液透析通路的经皮血管腔内动静脉内瘘创建现状综述
Cardiovasc Intervent Radiol. 2019 Jan;42(1):1-9. doi: 10.1007/s00270-018-2037-6. Epub 2018 Jul 20.
9
Early results of percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System.Ellipsys 血管通路系统经皮动静脉瘘创建的早期结果。
J Vasc Surg. 2018 Oct;68(4):1150-1156. doi: 10.1016/j.jvs.2018.01.036. Epub 2018 Apr 19.
10
The Pivotal Multicenter Trial of Ultrasound-Guided Percutaneous Arteriovenous Fistula Creation for Hemodialysis Access.超声引导下经皮动静脉内瘘成形术用于血液透析通路的关键多中心试验
J Vasc Interv Radiol. 2018 Feb;29(2):149-158.e5. doi: 10.1016/j.jvir.2017.10.015. Epub 2017 Dec 21.